Azure Bioscience: The director and CFO did not reduce their holdings and terminated the reduction plan

Jinshi data January 10 news, BluBio announced that the company's director and CFO Qiao Piyuan planned to reduce the company's shares by no more than 140,000 shares. As of now, Qiao Piyuan has not implemented the reduction. On January 10, the company received a notice from Qiao Piyuan, who decided to terminate the reduction plan in advance based on confidence in the company's future development prospects and a reasonable judgment of the company's value.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)